Market Closed -
Other stock markets
|
Pre-market 02:51:10 am | |||
93.18 EUR | +0.11% | 92.75 | -0.46% |
08:09am | France's Sanofi in COVID-19 vaccine deal with Novavax - statement | RE |
May. 09 | Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash | MT |
Sales 2024 * | 46.24B 49.82B | Sales 2025 * | 49.92B 53.79B | Capitalization | 116B 125B |
---|---|---|---|---|---|
Net income 2024 * | 7.13B 7.68B | Net income 2025 * | 8.66B 9.33B | EV / Sales 2024 * | 2.66 x |
Net Debt 2024 * | 6.56B 7.07B | Net Debt 2025 * | 1.95B 2.1B | EV / Sales 2025 * | 2.37 x |
P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
13.5
x | Employees | 86,088 |
Yield 2024 * |
4.13% | Yield 2025 * |
4.37% | Free-Float | 87.12% |
Latest transcript on Sanofi
1 day | +0.11% | ||
1 week | +1.39% | ||
Current month | +0.11% | ||
1 month | +6.83% | ||
3 months | +7.72% | ||
6 months | +8.25% | ||
Current year | +3.81% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Lise Kingo
BRD | Director/Board Member | 62 | 20-04-27 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 20-05-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.31% | 5 M€ | +4.56% | ||
3.66% | 0 M€ | -.--% | - | |
3.55% | 264 M€ | +13.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 93.18 | +0.11% | 1,139,451 |
24-05-08 | 93.08 | +1.31% | 1,258,175 |
24-05-07 | 91.88 | +0.94% | 1,069,033 |
24-05-06 | 91.02 | -0.31% | 605,355 |
24-05-03 | 91.3 | -0.65% | 891,417 |
Real-time Euronext Paris, May 09, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.81% | 125B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- SAN Stock